Name: UMIN ID:
Unique ID issued by UMIN | UMIN000022604 |
---|---|
Receipt number | R000026029 |
Scientific Title | Non-randomized, prospective, non-controlled study of changes of lipid parameters after introduction of evolocumab in patients with heterozygous familial hypercholesterolemia under LDL-apheresis therapy. |
Date of disclosure of the study information | 2016/06/04 |
Last modified on | 2020/02/13 20:44:38 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/06/04 14:22:16 | ||
2 | Update | 2016/12/08 13:08:20 | Recruitment status |
|
3 | Update | 2020/02/13 15:32:15 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
4 | Update | 2020/02/13 15:34:11 | Publication of results Number of participants that the trial has enrolled |
|
5 | Update | 2020/02/13 15:42:57 | Date of IRB Anticipated trial start date Last follow-up date |
|
6 | Update | 2020/02/13 20:44:38 | URL releasing protocol URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |